ATYR logo

aTyr Pharma, Inc. (ATYR) EBITDA

annual EBITDA:

-$66.37M-$14.20M(-27.21%)
December 31, 2024

Summary

  • As of today (September 1, 2025), ATYR annual EBITDA is -$66.37 million, with the most recent change of -$14.20 million (-27.21%) on December 31, 2024.
  • During the last 3 years, ATYR annual EBITDA has fallen by -$33.66 million (-102.91%).
  • ATYR annual EBITDA is now -450.41% below its all-time high of -$12.06 million, reached on December 1, 2012.

Performance

ATYR EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherATYRincome statement metrics

quarterly EBITDA:

-$19.93M-$4.54M(-29.47%)
June 1, 2025

Summary

  • As of today (September 1, 2025), ATYR quarterly EBITDA is -$19.93 million, with the most recent change of -$4.54 million (-29.47%) on June 1, 2025.
  • Over the past year, ATYR quarterly EBITDA has dropped by -$2.99 million (-17.68%).
  • ATYR quarterly EBITDA is now -998.78% below its all-time high of $2.22 million, reached on March 1, 2020.

Performance

ATYR quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherATYRincome statement metrics

TTM EBITDA:

-$68.89M-$2.99M(-4.54%)
June 1, 2025

Summary

  • As of today (September 1, 2025), ATYR TTM EBITDA is -$68.89 million, with the most recent change of -$2.99 million (-4.54%) on June 1, 2025.
  • Over the past year, ATYR TTM EBITDA has dropped by -$8.92 million (-14.87%).
  • ATYR TTM EBITDA is now -1102.92% below its all-time high of -$5.73 million, reached on March 1, 2014.

Performance

ATYR TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherATYRincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

ATYR EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-27.2%-17.7%-14.9%
3 y3 years-102.9%-62.0%-71.8%
5 y5 years-207.1%-234.6%-374.9%

ATYR EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-102.9%at low-174.7%at low-71.8%at low
5 y5-year-353.2%at low-324.5%at low-374.9%at low
alltimeall time-450.4%at low-998.8%at low-1102.9%at low

ATYR EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
-$19.93M(+29.5%)
-$68.89M(+4.5%)
Mar 2025
-
-$15.39M(-2.7%)
-$65.90M(-0.7%)
Dec 2024
-$66.37M(+27.2%)
-$15.82M(-10.9%)
-$66.37M(+0.4%)
Sep 2024
-
-$17.75M(+4.9%)
-$66.11M(+10.2%)
Jun 2024
-
-$16.93M(+6.7%)
-$59.97M(+7.1%)
Mar 2024
-
-$15.87M(+2.0%)
-$56.01M(+7.3%)
Dec 2023
-$52.18M(+16.7%)
-$15.55M(+33.8%)
-$52.18M(+18.9%)
Sep 2023
-
-$11.62M(-10.4%)
-$43.88M(-3.2%)
Jun 2023
-
-$12.97M(+7.8%)
-$45.34M(+1.5%)
Mar 2023
-
-$12.03M(+65.9%)
-$44.66M(-0.1%)
Dec 2022
-$44.71M(+36.7%)
-
-
Dec 2022
-
-$7.25M(-44.5%)
-$44.71M(-2.3%)
Sep 2022
-
-$13.08M(+6.3%)
-$45.78M(+14.2%)
Jun 2022
-
-$12.30M(+1.8%)
-$40.10M(+5.8%)
Mar 2022
-
-$12.08M(+45.2%)
-$37.89M(+15.8%)
Dec 2021
-$32.71M(+123.4%)
-$8.32M(+12.4%)
-$32.71M(+12.5%)
Sep 2021
-
-$7.40M(-26.6%)
-$29.09M(+4.3%)
Jun 2021
-
-$10.09M(+46.1%)
-$27.90M(+17.4%)
Mar 2021
-
-$6.91M(+47.1%)
-$23.77M(+62.3%)
Dec 2020
-$14.64M(-32.2%)
-$4.69M(-24.4%)
-$14.64M(-5.9%)
Sep 2020
-
-$6.21M(+4.3%)
-$15.56M(+7.3%)
Jun 2020
-
-$5.96M(-368.7%)
-$14.51M(+4.7%)
Mar 2020
-
$2.22M(-139.5%)
-$13.85M(-35.9%)
Dec 2019
-$21.61M
-$5.61M(+8.8%)
-$21.61M(-0.8%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$5.16M(-2.8%)
-$21.79M(-5.7%)
Jun 2019
-
-$5.30M(-4.3%)
-$23.11M(-16.2%)
Mar 2019
-
-$5.54M(-4.2%)
-$27.58M(-14.0%)
Dec 2018
-$32.07M(-30.9%)
-$5.78M(-10.8%)
-$32.07M(-14.1%)
Sep 2018
-
-$6.49M(-33.6%)
-$37.33M(-10.1%)
Jun 2018
-
-$9.77M(-2.7%)
-$41.52M(-4.5%)
Mar 2018
-
-$10.04M(-9.1%)
-$43.48M(-6.4%)
Dec 2017
-$46.43M(-20.5%)
-$11.04M(+3.4%)
-$46.43M(-2.7%)
Sep 2017
-
-$10.68M(-9.0%)
-$47.70M(-5.9%)
Jun 2017
-
-$11.73M(-9.6%)
-$50.67M(-6.4%)
Mar 2017
-
-$12.98M(+5.5%)
-$54.14M(-5.1%)
Dec 2016
-$58.44M(+25.0%)
-$12.31M(-9.8%)
-$57.04M(-6.5%)
Sep 2016
-
-$13.64M(-10.3%)
-$60.99M(+4.4%)
Jun 2016
-
-$15.21M(-4.2%)
-$58.44M(+8.4%)
Mar 2016
-
-$15.88M(-2.3%)
-$53.92M(+15.3%)
Dec 2015
-$46.75M(+105.7%)
-$16.26M(+46.6%)
-$46.75M(+28.7%)
Sep 2015
-
-$11.09M(+3.8%)
-$36.31M(+16.2%)
Jun 2015
-
-$10.69M(+22.7%)
-$31.24M(+21.5%)
Mar 2015
-
-$8.71M(+49.7%)
-$25.71M(+13.1%)
Dec 2014
-$22.73M(+20.7%)
-$5.82M(-3.3%)
-$22.73M(+34.4%)
Sep 2014
-
-$6.02M(+16.8%)
-$16.90M(+55.3%)
Jun 2014
-
-$5.16M(-10.0%)
-$10.88M(+90.0%)
Mar 2014
-
-$5.73M
-$5.73M
Dec 2013
-$18.83M(+56.1%)
-
-
Dec 2012
-$12.06M
-
-

FAQ

  • What is aTyr Pharma, Inc. annual EBITDA?
  • What is the all time high annual EBITDA for aTyr Pharma, Inc.?
  • What is aTyr Pharma, Inc. annual EBITDA year-on-year change?
  • What is aTyr Pharma, Inc. quarterly EBITDA?
  • What is the all time high quarterly EBITDA for aTyr Pharma, Inc.?
  • What is aTyr Pharma, Inc. quarterly EBITDA year-on-year change?
  • What is aTyr Pharma, Inc. TTM EBITDA?
  • What is the all time high TTM EBITDA for aTyr Pharma, Inc.?
  • What is aTyr Pharma, Inc. TTM EBITDA year-on-year change?

What is aTyr Pharma, Inc. annual EBITDA?

The current annual EBITDA of ATYR is -$66.37M

What is the all time high annual EBITDA for aTyr Pharma, Inc.?

aTyr Pharma, Inc. all-time high annual EBITDA is -$12.06M

What is aTyr Pharma, Inc. annual EBITDA year-on-year change?

Over the past year, ATYR annual EBITDA has changed by -$14.20M (-27.21%)

What is aTyr Pharma, Inc. quarterly EBITDA?

The current quarterly EBITDA of ATYR is -$19.93M

What is the all time high quarterly EBITDA for aTyr Pharma, Inc.?

aTyr Pharma, Inc. all-time high quarterly EBITDA is $2.22M

What is aTyr Pharma, Inc. quarterly EBITDA year-on-year change?

Over the past year, ATYR quarterly EBITDA has changed by -$2.99M (-17.68%)

What is aTyr Pharma, Inc. TTM EBITDA?

The current TTM EBITDA of ATYR is -$68.89M

What is the all time high TTM EBITDA for aTyr Pharma, Inc.?

aTyr Pharma, Inc. all-time high TTM EBITDA is -$5.73M

What is aTyr Pharma, Inc. TTM EBITDA year-on-year change?

Over the past year, ATYR TTM EBITDA has changed by -$8.92M (-14.87%)
On this page